Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in women aged 20-30 is often linked to deficiencies in Vitamin D, zinc, ferritin, and haemoglobin, as well as low SHBG levels in those with irregular periods.

Hormonal imbalances contribute to female hair loss, and trichoscopy is a useful diagnostic tool.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

PCOS is a common and costly condition in North American women, causing various health issues like obesity, diabetes, and fertility problems.

Telogen effluvium is a type of hair loss in women caused by many factors, and iron and thyroid tests are recommended for diagnosis.

A new plant extract from Avicennia marina could potentially be used to treat common hair loss.

The document concludes that thyroid disorders in children require specific treatments and monitoring, and educational resources are available for further information.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Cats lose hair due to itching or health issues, needing various tests for diagnosis.

The study found no link between anxiety, vitamin B12, folate, TSH, ferritin, zinc levels, and trichodynia in telogen alopecia patients.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

A child with a rare vitamin D-resistant condition improved with treatment.

Doctors vary in how they initially test for PCOS, but most agree on using oral contraceptives and lifestyle changes as first treatments.

The 39th Manfred Donike Workshop discussed methods for detecting misuse of steroids, gene doping, and the complexity of identifying drug residues in urine, highlighting the ongoing efforts to improve global anti-doping work.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

About 15% of US Army personnel use hair products containing hormone or placenta, with higher usage among non-whites, females, and enlisted personnel.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

A woman with acromegaloidism and normal growth hormone levels had a rare X-Tetrasomy, suggesting a need to study X-chromosome genes for their role in growth and facial development.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Lower SHBG levels may increase the risk of PCOS.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

Minoxidil response testing helps treat hair loss effectively and safely.